Literature DB >> 19283887

In vivo test of the vertical phase separation hypothesis: the display of major histocompatibility complex (MHC) class I molecules on membranes of B cells from mice fed high-fat diets.

Saame Raza Shaikh1, Sarah Boyle, Jing Hua, Zhiping Li, Michael Edidin.   

Abstract

The membrane vertical phase separation hypothesis predicts that a decrease in plasma membrane acyl chain order will increase major histocompatibility complex (MHC) class I surface expression. The hypothesis is based on modification of plasma membrane acyl chain order in cell culture and has not been tested in vivo. In the present study, we isolated splenic B cells from C57/BL6 mice fed either a normal diet or high-fat diets enriched in SFA or MUFA and assayed for changes in plasma membrane acyl chain order and MHC class I surface expression. Plasma membranes of B cells from MUFA-fed mice had significantly decreased acyl chain order and increased headgroup order. The decrease in acyl chain order correlated with a significant increase in the acyl chain unsaturation of B cells from the MUFA-fed mice. MHC class I surface levels on B cells were not affected by the MUFA-rich diet. This study suggests that the membrane vertical phase separation hypothesis may have limited application in a physiologically relevant setting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283887      PMCID: PMC2805455          DOI: 10.1017/s0007114508051544

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  20 in total

1.  Fluorescent lipid probes 12-AS and TMA-DPH report on selective, purinergically induced fluidity changes in plasma membranes of lymphoid cells.

Authors:  J Matkó; P Nagy
Journal:  J Photochem Photobiol B       Date:  1997-09       Impact factor: 6.252

2.  Influences of membrane curvature in lipid hexagonal phases studied by deuterium NMR spectroscopy.

Authors:  R L Thurmond; G Lindblom; M F Brown
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

Review 3.  Modulation of membrane proteins by vertical phase separation and membrane lipid fluidity. Basis for a new approach to tumor immunotherapy.

Authors:  C P Muller; G R Krueger
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

Review 4.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function.

Authors:  C D Stubbs; A D Smith
Journal:  Biochim Biophys Acta       Date:  1984-01-27

5.  Modification of membrane cholesterol level affects expression and clustering of class I HLA molecules at the surface of JY human lymphoblasts.

Authors:  A Bodnár; A Jenei; L Bene; S Damjanovich; J Matkó
Journal:  Immunol Lett       Date:  1996-12       Impact factor: 3.685

6.  Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1.

Authors:  W L Blok; M F de Bruijn; P J Leenen; W M Eling; N van Rooijen; E R Stanley; W A Buurman; J W van der Meer
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

Review 7.  The effects of non-lamellar forming lipids on membrane protein-lipid interactions.

Authors:  C D Stubbs; S J Slater
Journal:  Chem Phys Lipids       Date:  1996-07-15       Impact factor: 3.329

8.  Changes in cell-surface expression of MHC and Thy-1.2 determinants following treatment with lipid modulating agents.

Authors:  C P Muller; D A Stephany; M Shinitzky; J R Wunderlich
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

9.  Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes.

Authors:  D A Hughes; A C Pinder; Z Piper; I T Johnson; E K Lund
Journal:  Am J Clin Nutr       Date:  1996-02       Impact factor: 7.045

Review 10.  Dietary fat, insulin sensitivity and the metabolic syndrome.

Authors:  G Riccardi; R Giacco; A A Rivellese
Journal:  Clin Nutr       Date:  2004-08       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.